Connect with us

Markets

Visualizing the Future of the Pharma Market

Published

on

Drug Market Outlook

Visualizing the Future of the Pharma Market

Around the world, people are living longer.

By 2050, there will be two billion people that are 60 years or older globally. Meanwhile, the amount of seniors (65+ years old) in the U.S. will double to 100 million by 2060.

To meet the needs of this aging population, we will continue to need larger quantities and more varieties of prescription drug treatments – an industry that is expected to skyrocket to $1.2 trillion in size by 2024.

Drug Sales, by Segment

Today’s infographic comes to us from Raconteur, and it highlights the most anticipated drug treatments and therapy areas for the pharmaceutical industry.

It starts by breaking down the massive pharma market into therapy segments, showing a forecast for the size and growth for each category.

Here is the data for the top 15 segments, sorted by projected worldwide prescription drug sales in 2024:

RankTherapy Area2017 sales2024 salesCAGR
#1Oncology$104B$233B+12.2%
#2Anti-diabetics$46.1B$59.5B+3.3%
#3Anti-rheumatics$55.7B$56.7B+0.2%
#4Vaccines$27.7B$44.6B+7.1%
#5Anti-virals$42.4B$39.9B-0.9%
#6Immunosuppressants$13.7B$38.1B+15.7%
#7Bronchodilators$27.2B$32.3B+2.5%
#8Dermatologicals$12.9B$30.3B+13%
#9Sensory Organs$21.6B$26.9B+3.2%
#10Anti-hypertensives$23B$24.4B+0.8%
#11Anti-coagulants$16.8B$22.9B+4.6%
#12MS Therapies$22.7B$21.5B-0.8%
#13Anti-fibrinolytics$12.7B$20.4B+7.1%
#14Anti-hyperlipidaemics$11.3B$16.4B+5.5%
#15Anti-anaemics$7.6B$15.7B+11%
Other$379B$567B+5.9%
Total$825B$1249B+6.1%

This data, which comes from a recent report from EvaluatePharma, helps showcase a few key insights.

Firstly, the oncology therapy area – which makes drugs that are used to treat various forms of cancer – is by far the largest in the pharma world with $107 billion in sales in 2017. It’s also projected to maintain its dominance going forward, growing at an impressive 12.2% CAGR to $233 billion by 2024.

Next, while sales in cancer-related drugs will be the most in absolute terms, the fastest growing treatment area is actually in immunosuppressants – a segment of drugs that make a body less likely to reject a transplanted organ, such as a liver, heart, or kidney. It’s projected that this segment will grow at 15.7% per year, eventually becoming the sixth largest pharma segment at $38.1 billion in 2024.

Lastly, while sales in the pharma market will be averaging 6.1% in annual growth as a whole, there are two major segments that will see negative annual growth going forward: Anti-virals (-0.9%) and MS Therapies (-0.8%).

The Battle Against Cancer

Currently, there are more drugs used for treating cancer than for any other type of disease or condition.

RankDisease or ConditionNumber of active drugs
#1Breast cancer727
#2Lung cancer544
#3Colorectal cancer503
#4Ovarian cancer434
#5Pancreatic cancer430
#6Type-2 diabetes407
#7Prostate cancer381
-Alzheimer's disease381

Unfortunately, even though many cancer drugs are available on the market already, the debilitating disease is still a leading cause of death. Existing drugs are used in treatments of chemotherapy or hormone therapy, but it’s clear that there is still plenty of room for progress to be made against the disease.

For these reasons – combined with the estimate that nearly 40% of Americans will be diagnosed with some form of cancer during their lifetimes – it’s no surprise to see that companies have yet even more cancer drugs in the pipeline:

RankTherapy areaNumber of drugs in pipeline
#1Anti-cancer5,212
#2Biotechnology4,751
#3Neurological2,604
#4Anti-infective2,238
#5Alimentary/metabolic2,237
#6Reformulations2,073
#7Musculoskeletal1,597
#8Dermatological929

As more drugs get approved from the above pipeline, it is projected that $1 of every $5 spent on prescription drugs in 2024 will be going towards cancer-related treatments.

Click for Comments

Markets

Which Retailers Operate in the Most Countries?

From fast-fashion giant H&M to Apple, we show the top retailers globally with the largest international presence.

Published

on

This treemap shows the top retailers operating in the most countries in 2023.

The Top Retailers Operating in the Most Countries

This was originally posted on our Voronoi app. Download the app for free on iOS or Android and discover incredible data-driven charts from a variety of trusted sources.

Today, international expansion is a key growth strategy for the world’s top retailers as companies target untapped markets with the highest potential to drive revenue and profit streams.

While traditional retailers have sought out digital strategies as the industry evolves and consumer behaviors change, physical storefronts continue to be a dominant driver of retail sales. In 2023, brick-and-mortar sales comprised 81% of retail sales globally.

This graphic shows the top retailers operating in the most markets worldwide, based on data from the National Retail Federation.

Global Retailers With the Largest International Footprint

Here are the global retailers with the widest-reaching presence around the world in 2023:

RankingRetailerNumber of Countries of First-Party OperationHeadquarters
1H&M68🇸🇪 Sweden
2IKEA51🇳🇱 Netherlands
3Inditex45🇪🇸 Spain
4Decathlon34🇫🇷 France
5Carrefour32🇫🇷 France
6Sephora (LVMH)31🇫🇷 France
7Schwarz Group30🇩🇪 Germany
8Fast Retailing27🇯🇵 Japan
9Euronics International25🇳🇱 Netherlands
10Apple25🇺🇸 U.S.

Notably, eight of the top 10 companies with the widest market reach hail from Europe.

Fast-fashion giant H&M ranks first overall, with 4,454 stores across 68 countries last year. In 2023, the Swedish company earned $21.6 billion in revenues, with its largest markets by number of store locations being the U.S., Germany, and the UK. This year, it plans to open 100 new stores in growth markets, along with shutting down 160 stores in established locations, ultimately decreasing its global store count.

In second is IKEA, with a presence in 51 countries. Last year, the company expanded its footprint in India, launching its first store in the tech hub, Hyderabad. While the company has a broad international reach, its number of storefronts is a fraction of H&M, at 477 total stores worldwide.

Looking beyond the continent, Japan’s Fast Retailing is the top retailer in Asia, operating in 27 countries globally. As the parent company to fashion brand Uniqlo, it also stands as the seventh most valuable listed firm by market capitalization in the country.

Additionally, Apple is the sole American company to make this list, with storefronts in 25 countries. Overall, the company operates four types of retail stores: regular, AppleStore+, flagships, and flagship+. Regular stores often earn $40 million annually, while flagship+ stores typically earn more than $100 million.

By 2027, the company plans to build or remodel 53 stores globally, with the majority located in the U.S. and China.

Continue Reading
Visualizing Asia's Water Dilemma

Subscribe

Popular